The Runt domain transcription factor, RUNX3, has been shown to be a tumor suppressor in a variety of cancers including gastric, colon and breast cancer. Interestingly, an oncogenic role for RUNX3 has also been suggested in basal cell carcinoma and head and neck cancer. Here, we explore the role of RUNX3 in ovarian cancer.
Bibliographical noteCopyright © 2011 Elsevier Inc. All rights reserved.
- Gene Expression Profiling
- Ovarian Neoplasms
- Core Binding Factor Alpha 3 Subunit
- Cell Line, Tumor